We are happy to announce the release of our new white paper on remote monitoring and the challenges and benefits that COVID-19 pandemics brought to it. You can download for…
Continue readingBefore we review the challenges of using electronic medical records (EMR) we can start with the reality before EMR. Back in the days when all documents were on paper and…
Continue readingIn order to identify the correct dose of any therapeutic agent there are 2 pharmacological phases: Pharmacokinetic phase in which the dose, dosage form, frequency, and route of administration are…
Continue readingOur next webinar, organised by Moolya, will be on 23rd of Jul 2020. The topic will be regarding medical devices used in clinical trials as part of the data collection…
Continue readingAccording to current data average time and cost of a new drug to reach the market is 12 years and costs £1.15 billion but what is not included in this…
Continue readingThose who have worked on clinical trials for many years probably remember the rigidity of the clinical protocols and how often clinicians complained that the study design is out of…
Continue readingIt is not a secret that the research and development in the pharmaceutical industry is very costly, time-consuming, risky and not particularly efficient. According to estimates bringing new drugs on…
Continue readingChimeric antigen receptor (CAR) T cells have been studied for over 25 years and are very successful in some types of cancer. With more than 30 million people living with…
Continue readingThe most common spread of metastatic solid tumours in central nerve system (CNS) is as parenchymal brain metastases or as leptomeningeal disease (metastases in brain membrane or spinal cord). Because…
Continue readingFDA extended access program started back in 2009 and it allowed patients with life-threatening diseases who have exhausted all other options to try experimental drugs, which are not on the…
Continue reading